Control of metastasized pancreatic carcinomas in SCID/beige mice with human IL-2/TKD-activated NK cells

Journal of Immunology

Volumn 176, Issue 10, 2006, Pages 6270-6276

  Stangl, Stefan ^a   Wortmann, Andreas ^a,b   Guertler, Ulrich ^a,c   Multhoff, Gabriele ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^b UNIVERSITY OF ULM   (Germany)

^c BOEHRINGER INGELHEIM RCV GMBH AND CO KG   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

HEAT SHOCK PROTEIN 70; INTERLEUKIN 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CONTROL; CELL INFILTRATION; CYTOLYSIS; FEMALE; HUMAN; HUMAN CELL; LIFE EXPECTANCY; LIVER METASTASIS; MALE; METASTASIS; MOUSE; NATURAL KILLER CELL; NONHUMAN; PANCREAS CARCINOMA; PRIORITY JOURNAL; SCID MOUSE; T LYMPHOCYTE; TUMOR GROWTH; TUMOR VOLUME; TUMOR XENOGRAFT;

EID: 33646484351     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.176.10.6270     Document Type: Article

References (41)

1. Evans D. B., J. L. Abbruzzese, and T. R. Rich. 1997. Cancer of the pancreas. In Cancer Principles and Practice of Oncology, 5th Ed. V. T. De Vita, S. Hellmann, and S. A. Rosenberg, eds. Lippincott Williams & Wilkins, Philadelphia, pp. 1054-1087.
2. Bouvet, M., K. F. Binmoeller, and A. R. Moossa. 2001. Diagnosis of adenocarcinoma of the pancreas. In American Cancer Society Atlas of Clinical Oncology, J. L. Cameron, ed. B. C. Decker, Hamilton, Ontario, Canada, pp. 67-86.
3. Le, X., Q. Shi, B. Wang, Q. Xiong, C. Qian, Z. Peng, X. Li, H. Tang, J. Abruzzese, and K. Xie. 2000. Molecular regulation of constitutive expression of interleukin-8 in human pancreatic adenocarcinoma. J. Interferon Cytokine Res. 20; 935-946.
4. Shi, Q., X. Le, J. L. Abbruzzese, B. Wang, N. Mujaida, K. Matsushima, S. Huang, Q. Xiong, and K. Xie. 1999. Cooperation between transcription factor AP-1 and NF-κB in the induction of interleukin-8 in human pancreatic adenocarcinoma cells by hypoxia. J. Interferon Cytokine Res. 19: 1363-1371.
5. Hoffman, R. M. 1999. Orthotopic metastatic mouse models for anti-cancer drug discovery and evaluation: a bridge to the clinic. Invest. New Drugs 17: 343-359.
6. Shi, Q., and K. Xie. 2000. Experimental animal models of pancreatic cancer (review). Int. J. Oncol. 17: 217-225.
7. Vezeridis, M. P., C. M. Doremus, L. M. Tibbetts, O. Tzanakakis, and B. T. Jackson. 1989. Invasion and metastasis following orthotopic transplantation of human pancreatic cancer in the nude mouse. J. Surg. Oncol. 40: 261-265.
8. Wang, B., Q. Shi, J. L. Abbruzzese, Q. Xiong, X. Le, and K. Xie. 2001. A novel, clinically relevant animal model of metastatic pancreatic adenocarcinoma biology and therapy. Int. J. Pancreatol. 29: 37-46.
9. Srivastava, P. K., A. Menoret, S. Basu, R. J. Binder, and K. L. McQuade. 1998. Heat shock proteins come of age: primitive functions acquire new roles in an adoptive world. Immunity 8: 657-665.
10. Tamura, Y., P. Peng, K. Liu, M. Daou, and P. K. Srivastava. 1997. Immunotherapy of tumors with autologous tumor-derived heat shock protein preparations. Science 278: 117-120.
11. Asea, A., S. K. Kraeft, E. A. Kurt-Jones, M. A. Stevenson, L. B. Chen, R. W. Finberg, O. C. Koo, and S. K. Calderwood. 2000. Hsp70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and Cytokine. Nat. Med. 6: 435-442.
12. Todryk, S., A. A. Melcher, N. Hardwick, E. Linardakis, A. Bateman, M. P. Colombo, A. Stoppacciaro, and R. O. Vile. 1999. Heat shock protein 70 induced during tumor cell killing induces Th1 cytokines and targets immature dendritic cell precursors to enhance antigen uptake. J. Immunol. 163: 1398-1408.
13. Todryk, S. M., M. J. Gough, and O. Pockley. 2003. Facets of heat shock protein. 70 show immunotherapeutic potential. Immunology 110; 1-9.
14. Massa, C., C. Guiducci, A. Arioli, M. Parenza, M. P. Colombo, and C. Melani. 2004. Enhanced efficacy of tumor cell vaccines transfected with secretable hsp70. Can. Res. 64: 1502-1508.
15. Multhoff, G., C. Botzler, L. Jennen, J. Schmidt, J. Ellwart, and R. D. Issels. 1997. Heat shock protein 72 on tumor cells: a recognition structure for natural killer cells. J. Immunol. 158: 4341-4350.
16. Gao, B., and M. F. Tsan. 2004. Induction of cytokines by heat shock proteins and endotoxin in murine macrophages. Biochem. Biophys. Res. Commun. 317: 1149-1154.
17. Hauser, H., L. Shen, Q. L. Ou, S. Krueger, and S. Y. Chen. 2004. Secretory heat-shock protein as a dendritic cell-targeting molecule: a new strategy to enhance the potency of genetic vaccines. Gene Ther. 11: 924-927.
18. Ferrarini, M., S. Heltai, M. R. Zocchi, and C. Rugarli. 1992. Unusual expression and localization of heat-shock proteins in human tumor cells. Int. J. Cancer 51: 613-619.
19. Shin, B. K., H. Wang, A. M. Yim, F. LeNaor, F. Brichory, J. H. Jang, R. Zhao, E. Puravs, J. Tra, C. W. Michael, et al. 2003. Global profiling of the cell surface of cancer cells uncovers an abundance of proteins with chaperone function. J. Biol. Chem. 278: 7607-7617.
20. Multhoff, G., C. Botzler, M. Wiesnet, E. Muller, T. Meier, W. Wilmanns, and R. D. Issels. 1995. A stress-inducible 72-kDa heat-shock protein (Hsp72) is expressed on the surface of human tumor cells, but not on normal cells. Int. J. Cancer 61: 272-279.
21. Gastpar, R., C. Gross, L. Rossbacher, J. Ellwart, J. Riegger, and G. Multhoff. 2004. The cell surface-localized heat shock protein 70 epitope TKD induces migration and cytolytic activity selectively in human NK cells. J. Immunol. 172: 972-980.
22. Hantschel, M., K. Pfister, A. Jordan, R. Scholz, R. Andreesen, G. Schmitz, H. Schmetzer, W. Hiddemann, and G. Multhoff. 2000. Hsp70 plasma membrane expression on primary tumor biopsy material and bone marrow of leukemic patients. Cell Stress Chaperones 5: 438-442.
23. Gross, C., D. Hansch, R. Gastpar, and G. Multhoff. 2003. Interaction of heat shock protein 70 peptide with NK cells involves the NK receptor CD94. Biol. Chem. 384: 267-279.
24. Botzler, C., G. Li, R. D. Issels, and G. Multhoff. 1998. Definilion of extracellular localized epitopes of Hsp70 involved in an NK immune response. Cell Stress Chaperones 3: 6-11.
25. Mullhoff, G., K. Pfister, M. Gehrmann, M. Hantschel, C. Gross, M. Hafner, and W. Hiddemann. 2001. A 14-mer Hsp70 peptide stimulates natural killer (NK) cell activity. Cell Stress Chaperones 6: 337-344.
26. Moser, C., C. Schmidbauer, U. Guertler, C. Gross, M. Gehrmann, G. Thonigs, K. Pfister, and G. Multhoff. 2002. Inhibition of tumor growth in mice with severe combined immunodeficiency is mediated by heal shock protein 70 (Hsp70)-peptide-activated, CD94 positive natural killer cells. Cell Stress Chaperones 7: 365-373.
27. Basse, P. H., T. L. Whiteside, W. Chambers, and R. B. Herberman. 2001. Therapeutic activity of NK cells against tumors. Int. Rev. Immunol. 20: 439-501.
28. Kondo, E., K. Koda, N. Takiguchi, K. Oda, K. Seike, M. Ishizuka, and M. Miyazaki. 2003. Preoperative natural killer cell activity as a prognostic factor for distant metastasis following surgery for colon cancer. Dig. Surg. 20: 445-451.
29. Koda, K., N. Saito, K. Oda, K. Seike, E. Kondo, M. Ishizuka, N. Takiguchi, and M. Miyazaki. 2003. Natural killer cell activity and distant metastasis in rectal cancers treated surgically with and without neoadjuvant chemoradiotherapy. J. Am. Coll. Surg. 197: 254-260.
30. Yang, Q., M. E. Hokland, J. L. Bryant, Y. Zhang, U. Naamark, S. C. Watkins, R. H. Goldfarb, R. B. Herberman, and P. H. Basse. 2003. Tumor-localization by adoptively transferred, interleukin-2-activated NK cells leads to destruction of well-established lung metastases. Int. J. Cancer 105: 512-519.
31. Lozupone, F., D. Pende, V. L. Burgio, C. Castelli, M. Spada, M. Venditti, F. Lucani, L. Lugini, C. Federici, C. Ramoni, et al. 2004. Effect of human natural killer and γδ T cells on the growth of human autologous melanoma xenografts in SCID mice. Cancer Res. 64: 378-385.
32. Morgan, R. T., L. K. Woods, G. E. Moore, L. A. Quinn, L. McGavran, and S. G. Gordon. 1980. Human cell line (COLO 357) of metaslalic pancrealic adenocarcinoma. Int. J. Cancer 25: 591-598.
33. Gross, C., I. G. Schmidt-Wolf, S. Nagaraj, R. Gastpar, J. Ellwart, L. A. Kunz-Schughart, and G. Multhoff. 2003. Cell Stress Chaperones 8: 348-344.
34. MacDonald, H. R., H. D., Engers, J. C., Cerottini, and K. T. Brunner. 1974. Generalion of cytotoxic T lymphocytes in vitro. J. Exp. Med. 140: 718-721.
35. Ruggeri, L., M. Capanni, E. Urbani, W. D. Perruccio, A. Shlomchik, S. Tosli, D. Posati, F. Rogaia, F. Frassoni, M. Aversa, M. F. Martelli, and A. Velardi. 2002. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 295: 2097-2100.
36. Gastpar, R., M. Gehrmann, M. A. Bausero, A. Asea, C. Gross, J. Schroeder, and G. Multhoff. 2005. Heat shock protein 70 surface-positive tumor exosomes stimulate migratory and cytolytic activity of natural killer cells. Cancer Res. 65: 5238-5247.
37. Bausero, M. A., R. Gastpar, G. Multhoff, and A. Asea. 2005. Alternative mechanism by which IFN-γ enhances tumor recognition: active release of heat shock protein 72. J. Immunol. 175: 2900-2912.
38. Lancaster, G. I., and M. A. Febbraio. 2005. Exosome-dependent trafficking of Hsp70. J. Biol. Chem. 280: 23349-23355.
39. + T cell-independent pathway for anti-tumor CTL induction. Blood 106: 338-344.
40. Multhoff, G., T. Meier, C. Bolzler, M. Wiesnet, A. Allenbacher, W. Wilmanns, and R. D. Issels. 1995. Differential effects of ifosfamide upon the capacity of cyloloxic T lymphocytes and natural killer cells to lyse their target cells correlate with intracellular glutathione levels. Blood 85: 2124-2131.
41. Krause, S. W., R. Gastpar, R. Andreesen, C. Gross, H. Ullrich, G. Thonigs, K. Pfisler, and G. Multhoff. 2004. Treatmenl of colon and lung cancer patients with ex vivo heat shock protein 70-peptide-activated, autologous nalural killer cells: a clinical phase I trial. Clin. Cancer Res. 10: 3699-3707.